Ritzel M W, Yao S Y, Huang M Y, Elliott J F, Cass C E, Young J D
Department of Physiology, University of Alberta, Edmonton, Canada.
Am J Physiol. 1997 Feb;272(2 Pt 1):C707-14. doi: 10.1152/ajpcell.1997.272.2.C707.
We report identification of a new human nucleoside transporter protein by molecular cloning and functional expression of its cDNA. Previously, we used expression selection in Xenopus oocytes to isolate a cDNA from rat jejunal epithelium encoding the pyrimidine-selective Na+-dependent nucleoside transporter rCNT1 (Q.-Q. Huang, S. Y. M. Yao, M. W. L. Ritzel, A. R. P. Paterson, C. E. Cass, and J. D. Young. J. Biol. Chem. 269: 17757-17760, 1994). cDNAs for a human homologue of rCNT1, designated hCNT1, have been isolated from human kidney by hybridization cloning and reverse transcriptase polymerase chain reaction amplification strategies. hCNT1 was 83% identical to rCNT1 in amino acid sequence and exhibited the transport characteristics of an Na+-dependent nucleoside transporter with selectivity for pyrimidine nucleosides and adenosine when expressed in Xenopus oocytes. Deoxyadenosine, which undergoes net renal secretion, and guanosine were poor permeants. hCNT1 did, however, transport 3'-azido-3'-deoxythymidine. This is the first demonstration that members of the CNT family exist in human cells and provides evidence of their involvement in the renal transport of physiological nucleosides and nucleoside drugs. The hCNT1 gene was mapped to chromosome 15q25-26.
我们通过分子克隆及其cDNA的功能表达报告了一种新的人类核苷转运蛋白的鉴定。此前,我们利用非洲爪蟾卵母细胞中的表达筛选,从大鼠空肠上皮中分离出一种编码嘧啶选择性Na⁺依赖性核苷转运蛋白rCNT1的cDNA(Q.-Q. 黄、S.Y.M. 姚、M.W.L. 里泽尔、A.R.P. 帕特森、C.E. 卡斯和J.D. 杨。《生物化学杂志》269: 17757 - 17760, 1994)。通过杂交克隆和逆转录酶聚合酶链反应扩增策略,已从人肾中分离出rCNT1的人类同源物(命名为hCNT1)的cDNA。hCNT1在氨基酸序列上与rCNT1有83%的同一性,当在非洲爪蟾卵母细胞中表达时,表现出Na⁺依赖性核苷转运蛋白的转运特性,对嘧啶核苷和腺苷具有选择性。经肾脏净分泌的脱氧腺苷和鸟苷是较差的通透物。然而,hCNT1确实能转运3'-叠氮-3'-脱氧胸苷。这是首次证明CNT家族成员存在于人类细胞中,并为它们参与生理性核苷和核苷药物的肾脏转运提供了证据。hCNT1基因定位于染色体15q25 - 26。